10-K/A: American Vanguard Corp. Files 10-K/A, Reports Goodwill Impairment

American Vanguard Corporation has filed an amendment to its 2025 10-K, primarily to correct auditor's report details and confirm financial statement coverage, while also reporting a significant goodwill impairment and net loss for the fiscal year.

Summary

• This filing is an amendment (10-K/A) to American Vanguard Corporation's Annual Report for the fiscal year ended December 31, 2025.
• The amendment corrects the auditor's report to confirm it covers three years of financial statements and revises the accrued program costs from $54.6 million to $52.2 million.
• The company reported a net loss of $49.9 million for the year ended December 31, 2025, compared to a net loss of $126.3 million in 2024 and a net income of $7.5 million in 2023.
• Total assets decreased to $596.5 million in 2025 from $636.7 million in 2024.
• Total liabilities increased slightly to $404.1 million in 2025 from $403.6 million in 2024.
• Stockholders' equity decreased to $192.4 million in 2025 from $233.1 million in 2024.
• A significant goodwill impairment of $21.0 million was recorded for the international reporting unit in 2025.
• Long-term debt increased to $174.0 million in 2025 from $147.3 million in 2024.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to significant goodwill impairment, net losses, and a substantial increase in accrued program costs, despite some positive adjustments in the auditor's report.

Positives

• The auditor's report was corrected to accurately reflect coverage of three years of financial statements.
• Accrued program costs were corrected to $52.2 million, a reduction from the previously stated $54.6 million.
• Net sales for 2025 were $515.1 million, a decrease from $547.3 million in 2024, but gross profit increased to $147.6 million from $120.3 million.
• The company has a new credit facility in place as of March 13, 2026, with a $225,000 First Priority Term Loan and a $60,000 Second Priority Term Loan.
• Foreign currency translation adjustments resulted in a positive $6.7 million impact on comprehensive income in 2025.

Negatives

• The company reported a net loss of $49.9 million for the fiscal year ended December 31, 2025.
• Goodwill impairment of $21.0 million was recognized for the international reporting unit.
• Accrued program costs remain substantial at $52.2 million as of December 31, 2025.
• Inventories decreased to $176.0 million from $179.3 million, but remain a significant asset.
• Selling, general, and administrative expenses were $110.6 million in 2025, a decrease from $119.6 million in 2024, but still a large expense.
• Research, product development, and regulatory expenses were $23.2 million in 2025, down from $32.7 million in 2024.
• Transformation expenses were $7.2 million in 2025, down from $20.2 million in 2024.
• The company has a full valuation allowance against its net deferred income tax assets in the United States and other foreign operations totaling $41.4 million.

Risks

• The company recorded a goodwill impairment of $21.0 million for its international reporting unit, indicating potential overvaluation or underperformance of international assets.
• The company has a full valuation allowance against its net deferred income tax assets in the United States and other foreign operations, suggesting a lack of confidence in future taxable income in these regions.
• The company is subject to ongoing litigation, including DBCP cases and a product recall matter related to ornamental plants, which could result in significant financial liabilities.
• The company's credit facility has undergone multiple amendments, with reduced borrowing capacity and new financial covenants, indicating potential financial strain or restructuring.
• The company is undergoing a transformation project which has incurred significant expenses and asset impairments.
• The company faces risks associated with its reliance on a few major customers, with three customers accounting for 13%, 12%, and 12% of consolidated sales in 2025.

Future Outlook

The company has secured new credit facilities with a First Priority Term Loan of $225,000 and a Second Priority Term Loan of $60,000, effective March 13, 2026, with varying terms and covenants. A subsequent event indicates a plan to substantially reduce production activities at its Los Angeles facility by the second quarter of 2026, incurring estimated pre-tax charges of $8,000 to $10,000.

Management Comments

• The company is filing this amendment to correct specific details in the auditor's report and confirm coverage of financial statements.
• The company has implemented a new organization structure as part of its business transformation actions, including servicing Canadian customers within its U.S. Crop business starting January 1, 2025.
• The company is undergoing a digital and structural transformation project to improve operating leverage and identify process improvements.

Industry Context

StockSavvy.ai notes that the agricultural chemical industry is subject to regulatory scrutiny, environmental concerns, and cyclical demand. The significant goodwill impairment and net losses reported by American Vanguard Corporation may reflect challenges in the international market or the impact of ongoing transformation initiatives within this competitive landscape.

Comparison to Industry Standards

• The company's net loss of $49.9 million in 2025 contrasts with the profitability of many established players in the specialty chemical sector.
• The goodwill impairment of $21.0 million is a significant event, suggesting that the company's international segment may not be performing as expected, which could be a concern compared to competitors with more stable international operations.
• The increase in gross profit margin in 2025 (147.6 million on 515.1 million sales) compared to 2024 (120.3 million on 547.3 million sales) indicates improved cost management or pricing power, which is a positive trend that may align with industry best practices for margin improvement.
• The company's debt levels, with long-term debt at $174.0 million, need to be assessed against industry benchmarks for leverage, especially considering the recent refinancing and associated covenants.

Legal Proceedings

• The company paid a fine and entered into a three-year probation following a guilty plea to transporting hazardous waste without a manifest.
• Ongoing litigation includes DBCP cases, with approximately 40 claimants remaining, and tentative trial dates scheduled for the first half of 2026.
• A product recall matter related to ornamental plants resulted in customer claims totaling $9,063, with $1,414 paid as of December 31, 2025, and a liability of $7,649 recorded.
• The company is involved in a legal action against its third-party formulator, Turf Care Supply (TCS), and its private equity sponsor regarding the product recall matter.
• EPA Region IX issued a notice of violation regarding allegations of exporting 18 unregistered pesticides without submitting required Foreign Purchaser Acknowledgement Statements (FPAS).

Stakeholder Impact

• Shareholders are impacted by the net loss and significant goodwill impairment, which negatively affects equity value.
• Creditors are impacted by the refinancing of the company's debt, with new terms and covenants on the First and Second Priority Term Loans.
• Employees may be impacted by the planned reduction in production activities at the Los Angeles facility.
• Customers are impacted by potential product availability changes due to the transformation and production adjustments.

Next Steps

• The company plans to substantially reduce production activities at its Los Angeles manufacturing facility by the second quarter of 2026.
• The company will transfer production activities from Los Angeles to its Axis or Marsing facilities as part of its transformation plan.
• The company will incur estimated one-time pre-tax charges of $8,000 to $10,000 related to the plant reduction.
• The company is subject to a three-year probation period with an environmental compliance plan following a plea agreement for transporting hazardous waste.

Key Dates

Recommendation

The company's persistent net losses, significant goodwill impairment, ongoing litigation, and substantial accrued program costs indicate a challenging financial and operational environment. While the new credit facilities provide liquidity, the overall financial health and future outlook, coupled with the negative trends in key financial metrics, suggest a sell recommendation.

Keywords

American Vanguard Corporation, 10-K/A, Annual Report, Goodwill Impairment, Financial Statements, Net Loss, Accrued Program Costs, Deloitte & Touche